cbdMD Inc. (AMEX:YCBD) shares traded 9.94% higher at $0.25 on Wall Street last session.
In accordance with the data, 1 analysts cover cbdMD Inc. (AMEX:YCBD). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $5.00 and a low of $2.40, we find $3.70. Given the previous closing price of $0.23, this indicates a potential upside of 1508.7 percent. YCBD stock price is now -9.98% away from the 50-day moving average and -30.76% away from the 200-day moving average. The market capitalization of the company currently stands at $15.62M.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
It has been rated a hold by 1 analysts and a buy by 0. Brokers who have rated the stock have averaged $3.70 as their price target over the next twelve months.
.
A total of 29.26% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in YCBD stock. A new stake in cbdMD Inc. shares was purchased by TWO SIGMA SECURITIES, LLC during the first quarter worth $16,000. CHOREO, LLC invested $13,000 in shares of YCBD during the first quarter. In total, there are 56 active investors with 13.50% ownership of the company’s stock.
cbdMD Inc. (AMEX: YCBD) opened at $0.2500 on Tuesday. During the past 12 months, cbdMD Inc. has had a low of $0.20 and a high of $1.30. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 2.10, and a quick ratio of 1.20. The fifty day moving average price for YCBD is $0.2778 and a two-hundred day moving average price translates $0.3611 for the stock.
The latest earnings results from cbdMD Inc. (AMEX: YCBD) was released for Sep, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.03, beating analysts’ expectations of -$0.04 by 0.01. This compares to -$0.33 EPS in the same period last year. The company reported revenue of $6.08 million for the quarter, compared to $9.32 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -34.72 percent. For the current quarter, analysts expect YCBD to generate $11.5M in revenue.
cbdMD Inc.(YCBD) Company Profile
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
